Dear Subscriber, Circle April 30 on your calendar. That's when I believe a stunning announcement could begin to send shares of a tiny cancer detection company soaring. Why? Because this firm holds the patents to a $949 blood test that can detect over 50 cancers long before symptoms appear. And thanks to a Medicare-backed trial involving 50,000 seniors... I'm convinced the company is on the verge of nationwide coverage. If that happens? This tiny stock could become the go-to provider for 65 million seniors... And investors who get in now could see 5,000% or more in the years ahead. But after April 30? The secret's out and this potential 5,000% window could close fast. Click here now before the announcement breaks. Sincerely, Alexander Green Chief Investment Strategist, The Oxford Club |
Tidak ada komentar:
Posting Komentar